Xiaobing Jiang

947 total citations
41 papers, 672 citations indexed

About

Xiaobing Jiang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xiaobing Jiang has authored 41 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Immunology and 12 papers in Oncology. Recurrent topics in Xiaobing Jiang's work include Glioma Diagnosis and Treatment (11 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (9 papers). Xiaobing Jiang is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (9 papers). Xiaobing Jiang collaborates with scholars based in China, United States and Australia. Xiaobing Jiang's co-authors include Xiaoling Lü, Hongyang Zhao, Fangcheng Zhang, Ruen Liu, Yujie Zhou, Dongdong Xiao, Xing Huang, Hongyang Zhao, Xuan Wang and Zhiyong Xiong and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Xiaobing Jiang

38 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Jiang China 18 264 238 213 148 120 41 672
Davide Mangani United States 11 200 0.8× 295 1.2× 247 1.2× 126 0.9× 84 0.7× 19 625
Mahmoud S. Alghamri United States 13 198 0.8× 169 0.7× 136 0.6× 71 0.5× 168 1.4× 24 509
Daria S. Chulpanova Russia 15 442 1.7× 188 0.8× 238 1.1× 152 1.0× 134 1.1× 31 835
Jianming Wang China 16 355 1.3× 121 0.5× 193 0.9× 190 1.3× 33 0.3× 39 708
Patrick O. Azevedo Brazil 15 230 0.9× 105 0.4× 126 0.6× 88 0.6× 110 0.9× 19 605
Μαρκέλλα Ζαννίκου United States 10 262 1.0× 228 1.0× 203 1.0× 52 0.4× 108 0.9× 14 635
Yu Zeng China 14 390 1.5× 93 0.4× 82 0.4× 149 1.0× 53 0.4× 37 580
Emese Szabó Switzerland 16 351 1.3× 83 0.3× 122 0.6× 117 0.8× 123 1.0× 21 635
Esther D. Kers‐Rebel Netherlands 11 249 0.9× 363 1.5× 118 0.6× 50 0.3× 100 0.8× 20 574
Diahnn Futalan United States 8 216 0.8× 142 0.6× 87 0.4× 78 0.5× 128 1.1× 11 439

Countries citing papers authored by Xiaobing Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Jiang more than expected).

Fields of papers citing papers by Xiaobing Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Jiang. The network helps show where Xiaobing Jiang may publish in the future.

Co-authorship network of co-authors of Xiaobing Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Jiang. A scholar is included among the top collaborators of Xiaobing Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Jiang. Xiaobing Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Wen, Xiaobing Jiang, Peng Chen, et al.. (2025). Role of disturbance coefficient in monitoring and treatment of cerebral edema in patients with cerebral hemorrhage. World Journal of Clinical Cases. 13(14). 102534–102534.
2.
3.
Liu, Zhen, Li Zhang, Yi Rao, et al.. (2025). RIT1 Promotes the Proliferation of Gliomas Through the Regulation of the PI3K/AKT/c‐Myc Signalling Pathway. Journal of Cellular and Molecular Medicine. 29(2). e70362–e70362. 1 indexed citations
4.
Zhou, Yujie, et al.. (2023). EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma. Journal of Translational Medicine. 21(1). 28–28. 23 indexed citations
5.
Zheng, Jianglin, Qing Zhang, Zhen Zhao, et al.. (2023). Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1. Journal of Experimental & Clinical Cancer Research. 42(1). 127–127. 31 indexed citations
6.
Zhou, Yujie, Dongdong Xiao, & Xiaobing Jiang. (2022). LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification. Journal of Translational Medicine. 20(1). 335–335. 11 indexed citations
7.
Yu, Hao, Yizhong Peng, Zhipeng Wu, Minjie Wang, & Xiaobing Jiang. (2022). MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis. Translational Cancer Research. 11(7). 2249–2261. 4 indexed citations
8.
Wu, Yuxi, et al.. (2021). COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas. Frontiers in Oncology. 11. 752694–752694. 13 indexed citations
9.
Shi, Wei, Xiaomei Yang, Shenxia Xie, et al.. (2021). A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine. Cancer Letters. 522. 184–197. 33 indexed citations
10.
11.
Tian, Han, Nian Xiong, Xiaoming Liu, et al.. (2021). Efficacy and safety of general anesthesia deep brain stimulation for dystonia: an individual patient data meta-analysis of 341 cases. Neurological Sciences. 42(7). 2661–2671. 4 indexed citations
12.
Wang, Yihao, Fangcheng Zhang, Nanxiang Xiong, et al.. (2021). Remodelling and Treatment of the Blood-Brain Barrier in Glioma. Cancer Management and Research. Volume 13. 4217–4232. 37 indexed citations
13.
Xie, Jun, Qi Liu, Xiaobing Jiang, et al.. (2021). Psychological Health Issues of Medical Staff During the COVID-19 Outbreak. Frontiers in Psychiatry. 12. 611223–611223. 5 indexed citations
14.
Wang, Chen, Hongyi Xing, Xiaobing Jiang, et al.. (2019). Cerebral Phaeohyphomycosis Caused by Exophiala dermatitidis in a Chinese CARD9-Deficient Patient: A Case Report and Literature Review. Frontiers in Neurology. 10. 938–938. 23 indexed citations
15.
Wang, Xuan, Xiaoling Lü, Hongyang Zhao, Fangcheng Zhang, & Xiaobing Jiang. (2013). A novel recombinant protein of IP10-EGFRvIIIscFv and CD8+ cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice. Cancer Immunology Immunotherapy. 62(7). 1261–1272. 32 indexed citations
16.
Chen, Chia‐Hsiang, Weiwei Xiao, Xiaobing Jiang, et al.. (2013). A Novel Marine Drug, SZ-685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR-200c. Current Medicinal Chemistry. 20(16). 2145–2154. 27 indexed citations
17.
Jiang, Xiaobing, et al.. (2010). Use of dentritic cells pulsed with HLA-A2-restricted MAGE-A1 peptide to generate cytotoxic T lymphocytes against malignant glioma. Journal of Huazhong University of Science and Technology [Medical Sciences]. 30(5). 678–682. 3 indexed citations
18.
Lü, Xiaoling, Xiaobing Jiang, Ruen Liu, & Shengmin Zhang. (2008). The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. Vaccine. 26(42). 5352–5357. 36 indexed citations
19.
Lü, Xiaoling, et al.. (2008). Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response. Cancer Letters. 271(1). 129–139. 26 indexed citations
20.
Lü, Xiaoling, Xiaobing Jiang, Ruen Liu, Fangcheng Zhang, & Hongyang Zhao. (2007). Generation of allo-restricted cytotoxic T lymphocytes against malignant glioma by artificial antigen-presenting cells. Cancer Letters. 256(1). 128–135. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davide Mangani Breakdown of academic impact, for papers by Mahmoud S. Alghamri Breakdown of academic impact, for papers by Daria S. Chulpanova Breakdown of academic impact, for papers by Jianming Wang Breakdown of academic impact, for papers by Patrick O. Azevedo Breakdown of academic impact, for papers by Μαρκέλλα Ζαννίκου Breakdown of academic impact, for papers by Yu Zeng Breakdown of academic impact, for papers by Emese Szabó Breakdown of academic impact, for papers by Esther D. Kers‐Rebel Breakdown of academic impact, for papers by Diahnn Futalan
Rankless by CCL
2026